Skip Navigation
CNBC
Markets
  • Pre-Markets
  • U.S. Markets
  • Currencies
  • Cryptocurrency
  • Futures & Commodities
  • Bonds
  • Funds & ETFs
Business
  • Economy
  • Finance
  • Health & Science
  • Media
  • Real Estate
  • Energy
  • Climate
  • Transportation
  • Industrials
  • Retail
  • Wealth
  • Sports
  • Life
  • Small Business
Investing
  • Personal Finance
  • Fintech
  • Financial Advisors
  • Options Action
  • ETF Street
  • Buffett Archive
  • Earnings
  • Trader Talk
Tech
  • Cybersecurity
  • AI
  • Enterprise
  • Internet
  • Media
  • Mobile
  • Social Media
  • CNBC Disruptor 50
  • Tech Guide
Politics
  • White House
  • Policy
  • Defense
  • Congress
  • Expanding Opportunity
Video
  • Latest Video
  • Full Episodes
  • Livestream
  • Live Audio
  • Live TV Schedule
  • CNBC Podcasts
  • CEO Interviews
  • CNBC Documentaries
  • Digital Originals
Watchlist
Investing Club
  • Trust Portfolio
  • Analysis
  • Trade Alerts
  • Meeting Videos
  • Homestretch
  • Jim's Columns
  • Education
  • Subscribe
Join IC
PRO
  • Pro News
  • Josh Brown
  • Mike Santoli
  • Calls of the Day
  • My Portfolio
  • Livestream
  • Full Episodes
  • Stock Screener
  • Market Forecast
  • Options Investing
  • Chart Investing
  • Subscribe
Join Pro
Livestream
  • Make It
  • select
  • USA
  • INTL
  • Livestream
  • Livestream
Watchlist
SIGN IN
Create free account
Markets
Business
Investing
Tech
Politics
Video
Watchlist
Investing Club
Join IC
PRO
Join Pro
Livestream

Business News

Health and Science

  • Coronavirus
  • Biotech and Pharma
  • Health Insurance
  • Hospitals
  • Science
Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior’ to revised Pfizer offer
Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior’ to revised Pfizer offer
Annika Kim Constantino4 hours ago
Pfizer tops estimates, raises profit guidance even as sales fall
Pfizer tops estimates, raises profit guidance even as sales fall
Annika Kim Constantino4 hours ago
Pfizer files second lawsuit against Novo Nordisk, Metsera in obesity bidding war
Pfizer files second lawsuit against Novo Nordisk, Metsera in obesity bidding war
Annika Kim ConstantinoMon, Nov 3rd 2025
Where the blockbuster weight loss drug market stands today — and what’s coming next
Where the blockbuster weight loss drug market stands today — and what’s coming next
Annika Kim ConstantinoSun, Nov 2nd 2025
'Trump effect' raises hopes for cannabis rally as investors bet on change
'Trump effect' raises hopes for cannabis rally as investors bet on change
Luke FountainSat, Nov 1st 2025
Breast cancer drug stock Olema Pharmaceutical could more than double from here
Power Lunch
Breast cancer drug stock Olema Pharmaceutical could more than double from here
Thu, Oct 30th 2025
This biotech stock has jumped 50% in 3 months
Power Lunch
This biotech stock has jumped 50% in 3 months
Thu, Oct 30th 2025
Analysis
We're raising our Eli Lilly price target — what a difference a quarter makes
Thu, Oct 30th 2025
CNBC Changemakers
Midi Health introducing testosterone therapy as demand from women spikes
Thu, Oct 30th 2025
Health and Science
Eli Lilly blows past estimates, hikes guidance on Zepbound and Mounjaro sales
Thu, Oct 30th 2025

Trending Now

  • 1
    Government shutdown set to become longest ever after latest Senate vote fails
  • 2
    Trump suggests U.S. won't pay any SNAP benefits during shutdown, contradicting court filing
  • 3
    Bitcoin falls below $100,000 for the first time since late June
  • 4
    Stocks drop on rising fears about AI stock valuations, Palantir leads decline: Live updates
  • 5
    I’ve studied hundreds of highly successful kids: My No. 1 non-negotiable rule for raising resilient teens

More In Health and Science

Merck tops estimates on Keytruda strength and narrows profit outlook
Health and Science
Merck tops estimates on Keytruda strength and narrows profit outlook
Thu, Oct 30th 2025
FDA to speed up approvals of biosimilars as Trump targets high drug costs
Health and Science
FDA to speed up approvals of biosimilars as Trump targets high drug costs
Wed, Oct 29th 2025
Eli Lilly, Walmart to offer discounted retail option for obesity drug Zepbound
Health and Science
Eli Lilly, Walmart to offer discounted retail option for obesity drug Zepbound
Wed, Oct 29th 2025
Health and Science
CVS beats estimates, hikes guidance as insurance business improves
Wed, Oct 29th 2025
Health and Science
Eli Lilly, Nvidia to build supercomputer, AI factory for drug discovery
Tue, Oct 28th 2025
Healthy Returns
Healthy Returns: What to expect from Eli Lilly, Merck, AbbVie Q3 earnings
Tue, Oct 28th 2025
Novartis CEO says firm has the firepower for big M&A deals: 'Can never be done'
Earnings
Novartis CEO says firm has the firepower for big M&A deals: 'Can never be done'
Tue, Oct 28th 2025
Healthy Returns: A key step forward for Novo Nordisk's GLP-1 pill
Healthy Returns
Healthy Returns: A key step forward for Novo Nordisk's GLP-1 pill
Tue, Oct 21st 2025
Why cattlemen say Trump Argentine beef import idea no solution for record prices
State of Freight
Why cattlemen say Trump Argentine beef import idea no solution for record prices
Tue, Oct 21st 2025
Pharmaceuticals
Novo Nordisk chair and directors quit after boardroom rift
Tue, Oct 21st 2025
Tech
Anthropic's Claude Life Sciences will give researchers an AI efficiency boost
Mon, Oct 20th 2025
Health and Science
Eli Lilly, Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1s
Fri, Oct 17th 2025
Trump announces efforts to expand access to IVF drugs
Health and Science
Trump announces efforts to expand access to IVF drugs
Thu, Oct 16th 2025
Genentech to sell flu pill directly to some consumers at a discount
Health and Science
Genentech to sell flu pill directly to some consumers at a discount
Fri, Oct 17th 2025
DuPont prepares to spinoff electronics. What investors get with the remaining firm
Analysis
DuPont prepares to spinoff electronics. What investors get with the remaining firm
Fri, Oct 31st 2025
Economy
Wells Fargo, Pfizer CEOs caution U.S. could lose out to China without innovation
Thu, Oct 16th 2025
Analysis
Abbott disappoints again: We're downgrading it and considering what to do next
Wed, Oct 15th 2025
Leadership Insights
Higher education CEO on AI's growing role in health-care degree market
Tue, Oct 14th 2025
Oura reaches $11 billion valuation with new $900 million fundraise
CNBC Disruptor 50
Oura reaches $11 billion valuation with new $900 million fundraise
Tue, Oct 14th 2025
Lego MRI sets are reducing anxiety in children undergoing medical treatment
Entertainment
Lego MRI sets are reducing anxiety in children undergoing medical treatment
Mon, Oct 13th 2025
Trump reaches deal with AstraZeneca to lower U.S. drug prices
Health and Science
Trump reaches deal with AstraZeneca to lower U.S. drug prices
Fri, Oct 10th 2025
Workforce Wire
Teen AI chatbot texting is a 'huge, huge problem,' says Talkspace CEO
Fri, Oct 10th 2025
Healthy Returns
Healthy Returns: Amgen joins list of drugmakers selling directly to consumers
Tue, Oct 7th 2025
CNBC Changemakers
Laura Modi, CEO and mom, is breaking one of the market's biggest duopolies
Tue, Oct 7th 2025
CNBC logo
  • Subscribe to CNBC PRO
  • Subscribe to Investing Club
  • Licensing & Reprints
  • CNBC Councils
  • Select Personal Finance
  • CNBC on Peacock
  • Join the CNBC Panel
  • Supply Chain Values
  • Closed Captioning
  • Digital Products
  • News Releases
  • Internships
  • Corrections
  • About CNBC
  • Ad Choices
  • Site Map
  • Podcasts
  • Careers
  • Help
  • Contact
  • News Tips

    Got a confidential news tip? We want to hear from you.

    Get In Touch
  • CNBC Newsletters

    Sign up for free newsletters and get more CNBC delivered to your inbox

    Sign Up Now

    Get this delivered to your inbox, and more info about our products and services.

  • Advertise With Us

    Please Contact Us
  • Privacy Policy
  • California Consumer Privacy Act (CCPA) Opt-Out IconYour Privacy Choices
  • CA Notice
  • Terms of Service

© 2025 CNBC LLC. All Rights Reserved. A Division of NBCUniversal

Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Market Data Terms of Use and Disclaimers

Data also provided byReuters logo